• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dis. Active MERS-CoV replication and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for patho

Giuseppe

Emeritus
[Source: The Journal of Infectious Diseases, full page: (LINK). Abstract, edited.]


Active MERS-CoV replication and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis

Jie Zhou 1,2,3,*, Hin Chu 2,*, Cun Li 2, Bosco Ho-Yin Wong 2, Zhong-Shan Cheng 2, Vincent Kwok-Man Poon 2, Tianhao Sun 2, Candy Choi-Yi Lau 2, Kenneth Kak-Yuen Wong 5, Jimmy Yu-Wai Chan 5, Jasper Fuk-Woo Chan 1,2,3,4, Kelvin Kai-Wang To 1,2,3,4, Kwok-Hung Chan 2, Bo-Jian Zheng 1,2,3,4 and Kwok-Yung Yuen 1,2,3,4,#

Author Affiliations: <SUP>1</SUP>State Key Laboratory of Emerging Infectious Diseases <SUP>2</SUP>Department of Microbiology <SUP>3</SUP>Research Centre of Infection and Immunology <SUP>4</SUP>Carol Yu Centre for Infection <SUP>5</SUP>Department of Surgery; The University of Hong Kong, Hong Kong Special Administrative Region, China

#Correspondence: Kwok-Yung Yuen, Carol Yu Centre for Infection, Department of Microbiology, the University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Pokfulam, Hong Kong Special Administrative Region, China. Tel: 852-22554897. Fax: 852-28551241. Email: kyyuen@hkucc.hku.hk

* J.Z. and H.C. contributed equally to the study.


Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) caused severe pneumonia, multi-organ dysfunction and a higher fatality rate (50% versus 10%) than severe acute respiratory syndrome coronavirus (SARS-CoV). To understand the pathogenesis, we studied viral replication, cytokine/chemokine response and antigen presentation in MERS-CoV-infected human monocyte-derived macrophages (MDMs) versus SARS-CoV-infected-MDMs. Only MERS-CoV can replicate in MDMs. Both viruses were unable to significantly stimulate the expression of antiviral cytokines (IFN-α, IFN-β) but induced comparable levels of TNF-α and IL-6. Notably, MERS-CoV induced significantly higher expression levels of IL-12, IFN-γ and chemokines (IP-10/CXCL-10, MCP-1/CCL-2, MIP-1α/CCL-3, RANTES/CCL-5, IL-8) than SARS-CoV. The expression of MHC class I and costimulatory molecules were significantly higher in MERS-CoV-infected-MDMs than in SARS-CoV-infected-cells. MERS-CoV replication was validated by immunostaining of infected MDMs and ex-vivo lung tissue. We conclusively showed that MERS-CoV can establish a productive infection in human macrophages. The aberrant induction of inflammatory cytokines/chemokines could be important in the disease pathogenesis.


Received July 17, 2013. Revision received August 16, 2013. Accepted August 27, 2013. <CITE><ABBR>J Infect Dis.</ABBR> (2013) doi: 10.1093/infdis/jit504 </CITE>First published online: September 24, 2013.

? The Author 2013. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.

For Permissions, please e-mail: journals.permissions@oup.com.


-
-------
 
Back
Top